Other
Botox
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Botox is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
29
clinical trials
Completed20 · 69%
Recruiting3 · 10%
Terminated3 · 10%
Unknown status2 · 7%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
29 trials
EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients
Recruiting·—·N/A·NCT06075134·32 enrolled
BoTox Into the Sternocleidomastoid Muscles (SCM)
Recruiting·—·Phase 4·NCT06903975·30 enrolled
Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm
Completed·—·N/A·NCT01859507·32 enrolled
A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency
Completed·—·Phase 4·NCT01700387·20 enrolled
Change in Biting Force After Botox Injection
Completed·—·N/A·NCT04940104·20 enrolled
Comparative Study of the Effect of Dysport and Botox
Completed·—·Phase 4·NCT00434863·24 enrolled
Firdapse for Post-BOTOX Vocal Weakness
Completed·—·Phase 2·NCT05123053·18 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)